Crinetics Pharmaceuticals, Inc. (CRNX)
33.67
-2.64
(-7.27%)
USD |
NASDAQ |
Mar 27, 16:00
33.67
0.00 (0.00%)
After-Hours: 20:00
Crinetics Pharmaceuticals Shareholders Equity (Quarterly) : 992.08M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 3.996M |
| Nektar Therapeutics | 89.83M |
| Madrigal Pharmaceuticals, Inc. | 602.69M |
| Axsome Therapeutics, Inc. | 88.30M |
| Gossamer Bio, Inc. | -122.76M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.135B |
| Total Liabilities (Quarterly) | 143.41M |
| Debt to Equity Ratio | 0.0489 |
| Current Ratio | 12.32 |
| Net Debt Paydown Yield | 0.02% |